Adel Ekladious

Adel Ekladious serves as a Clinical Associate Professor within the Internal Medicine department at the UWA Medical School, The University of Western Australia, where he maintains an active clinical and research profile focused on complex renal and metabolic conditions. His scholarly contributions are concentrated in nephrology subspecialties with significant emphasis on pathophysiological mechanisms and clinical management strategies.

His research portfolio demonstrates deep expertise in Acute Kidney Injury, Metabolic Acidosis, and Renal Tubular Acidosis, as validated by fingerprint analysis showing 100% contribution to Acute Kidney Injury research and 76% to both Anion Gap and Metabolic Acidosis studies. This work spans critical clinical scenarios including pandemic-related dialysis challenges and novel pharmacotherapeutic approaches for chronic kidney disease.

Analysis of his 2024 publications reveals a cohesive research trajectory addressing urgent clinical questions in renal medicine, with particular attention to metabolic acidosis variants, SGLT2 inhibitor applications, and innovative dialysis methodologies during public health emergencies. These studies consistently bridge laboratory findings with bedside clinical practice.

While specific scientific awards are not documented in available sources, his scholarly impact is evidenced by an h-index of 16 and consistent citation metrics across multiple publications, including three articles with multiple Scopus citations in 2024 alone.

No information regarding student supervision, grant funding, or dedicated research teams is provided in the current documentation, though his collaborative publication record indicates active engagement with clinical researchers across multiple institutions.